
5-Hydroxy-1-methylhydantoin
CAS No. 84210-26-4
5-Hydroxy-1-methylhydantoin( NZ-419 | HD-003 )
Catalog No. M27907 CAS No. 84210-26-4
NZ-419 is an antioxidant potentially for the treatment of renal failure.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 302 | Get Quote |
![]() ![]() |
10MG | 444 | Get Quote |
![]() ![]() |
25MG | 711 | Get Quote |
![]() ![]() |
50MG | 1008 | Get Quote |
![]() ![]() |
100MG | 1341 | Get Quote |
![]() ![]() |
500MG | 2673 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product Name5-Hydroxy-1-methylhydantoin
-
NoteResearch use only, not for human use.
-
Brief DescriptionNZ-419 is an antioxidant potentially for the treatment of renal failure.
-
DescriptionNZ-419 is an antioxidant potentially for the treatment of renal failure. A creatinine metabolite, NZ-419, a hydroxyl radical scavenger, has previously been shown to confer renoprotection by inhibiting the progression of chronic kidney disease in rats. NZ-419 a novel anti-oxidant drug completely suppressed the expression of B2-kinin receptors (B2KR) in response to high glucose (25 mM) stimulation in VSMC and was also shown to attenuate the effects of BK on VSMC remodeling. NZ-419 inhibited the BK-induced increase in MAPK phosphorylation and attenuated the increase in connective tissue growth factor (CTGF) protein levels in VSMC. These findings suggest that NZ-419 may confer vascular protection against high glucose concentrations and BK-stimulation to ameliorate vascular injury and remodeling through its anti-oxidant properties.
-
In Vitro——
-
In Vivo——
-
SynonymsNZ-419 | HD-003
-
PathwayGPCR/G Protein
-
TargetBradykinin Receptor
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number84210-26-4
-
Formula Weight114.1
-
Molecular FormulaC4H6N2O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1NC(CN1C)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference



-
ELN 441958
ELN-441958 is a potent, neutral antagonist of B1 receptor, inhibits the binding of the B1 agonist ligand [3H]DAKD to IMR-90 cells with Ki of 0.26 nM.
-
Bradykinin (1-5)
Bradykinin (1-5) is a major stable metabolite of Bradykinin, formed by the proteolytic action of angiotensin-converting enzyme (ACE).The bradykinin (BK) fragment (1-5) (RPPGF) is among the most stable of naturally occurring metabolites. Bradykinin (1-5) may be used as a marker for BK production in vivo.
-
Bradykinin (acetate)
Bradykinin (acetate) is an active peptide that is generated by the kallikrein-kinin system. It is a inflammatory mediator and also recognized as a neuromediator and regulator of several vascular and renal functions. Enzymatically produced from kallidin in the blood, it is a powerful vasodilator that causes smooth muscle contraction, and may mediate inflammation.